ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $352,000 | +24.8% | 4,248 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $282,000 | -58.8% | 4,248 | -52.4% | 0.00% | -62.5% |
| Q4 2020 | $685,000 | +27.3% | 8,923 | -28.5% | 0.01% | +14.3% |
| Q3 2020 | $538,000 | -81.4% | 12,475 | -81.3% | 0.01% | -82.5% |
| Q2 2020 | $2,887,000 | +32.1% | 66,825 | -12.0% | 0.04% | +14.3% |
| Q1 2020 | $2,185,000 | -59.1% | 75,925 | -10.3% | 0.04% | -34.0% |
| Q4 2019 | $5,345,000 | +114.3% | 84,675 | -4.3% | 0.05% | +96.3% |
| Q3 2019 | $2,494,000 | +6.3% | 88,500 | 0.0% | 0.03% | +8.0% |
| Q2 2019 | $2,346,000 | +58.9% | 88,500 | +10.1% | 0.02% | +56.2% |
| Q1 2019 | $1,476,000 | +1254.1% | 80,400 | +900.0% | 0.02% | +1500.0% |
| Q2 2018 | $109,000 | – | 8,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |